931
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Combined therapy targeting AR and EZH2 curbs castration-resistant prostate cancer enhancing anti-tumor T-cell response

, , , , , , , , , & ORCID Icon show all
Pages 653-670 | Received 25 Oct 2023, Accepted 07 Mar 2024, Published online: 26 Mar 2024